• Prostate cancers in black men could be missed through active surveillance
    Prostate cancers in black men could be missed through active surveillance

News

Prostate cancers in black men could be missed through active surveillance

Prostate cancers in black men could be missed as a result of active surveillance, a new study has found.

The research from Johns Hopkins found that African-Americans diagnosed with low-risk prostate cancers are more likely than white men to have an aggressive disease that is unrecognised with existing diagnostic approaches.

A report of the study has been posted online in the Journal of Clinical Oncology, where it has been described as the biggest assessment of race-based health disparities in men diagnosed with a slow-growing, non-aggressive form of prostate cancer.

The findings highlighted that preoperative characteristics were similar for very-low-risk whites and blacks, but black men had worse Charlson comorbidity index scores, which assesses life expectancy.

A detailed analysis also showed that black men had a lower rate of organ-confined cancers at 87.9 per cent and a significantly higher hazard of prostate-specific antigen (PSA)-defined biochemical recurrence (BCR) of prostate cancer.

Urologist Edward M. Schaeffer, a co-author of the study, said: “This is critical information because if African-American men do have more aggressive cancers, as statistics would suggest, then simply monitoring even small cancers that are very low risk would not be a good idea because aggressive cancers are less likely to be cured.

“We think we are following a small, non-aggressive cancer, but in reality, this study highlights that in black men, these tumors are sometimes more aggressive than previously thought.”

He went on to say that alternate race-specific surveillance entry criteria should be developed and utilised for African-American men to guarantee oncologic parity with their white counterparts.

New strategies are also being developed to accurately risk-classify African-Americans with newly diagnosed prostate cancer, which should improve chances of survival.

However, Mr Schaeffer admitted that the figures are restricted because they are from a retrospective analysis of the experiences of a single academic medical centre.

Posted by Fiona Griffiths


Digital Edition

Lab Asia Dec 2025

December 2025

Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...

View all digital editions

Events

Smart Factory Expo 2026

Jan 21 2026 Tokyo, Japan

Nano Tech 2026

Jan 28 2026 Tokyo, Japan

Medical Fair India 2026

Jan 29 2026 New Delhi, India

SLAS 2026

Feb 07 2026 Boston, MA, USA

Asia Pharma Expo/Asia Lab Expo

Feb 12 2026 Dhaka, Bangladesh

View all events